You have 9 free searches left this month | for more free features.

whole-gland

Showing 1 - 25 of 5,723

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Prostate Cancer Recurrent Trial in Toronto (HDR brachytherapy)

Active, not recruiting
  • Prostate Cancer Recurrent
  • HDR brachytherapy
  • Toronto, Ontario, Canada
    Odette Cancer Centre, Sunnybrook Health Sciences Centre
May 3, 2022

Prostate Cancer Trial in Toronto (targeted focal HDR brachytherapy, Whole-gland HDR Brachytherapy)

Recruiting
  • Prostate Cancer
  • targeted focal HDR brachytherapy
  • Whole-gland HDR Brachytherapy
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Oct 4, 2021

Carcinoma Prostate Trial in Toronto (LDR/HDR)

Terminated
  • Carcinoma Prostate
  • LDR/HDR
  • Toronto, Ontario, Canada
    Sunnybrook Odette Cancer Centre
Apr 23, 2021

Prostate Cancer Trial in Toronto (MR-guided Radiotherapy Boost)

Not yet recruiting
  • Prostate Cancer
  • MR-guided Radiotherapy Boost
  • Toronto, Ontario, Canada
    University Health Network, Princess Margaret Hospital
Oct 6, 2022

Prostate Cancer Trial in Toronto (MRI assisted focal boost with HDR monotherapy)

Active, not recruiting
  • Prostate Cancer
  • MRI assisted focal boost with HDR monotherapy
  • Toronto, Ontario, Canada
    Sunnybrook Health Sciences Centre
Jun 12, 2022

Immune Biomarker Study for Salivary Gland Carcinoma

Not yet recruiting
  • Salivary Gland Tumor
  • Benign Salivary Gland Tumor
  • Sampling
  • Erlangen, Bavaria, Germany
  • +1 more
Sep 21, 2023

A Modified Calculation Formula for Meibomian Gland Grading

Completed
  • Meibomian Gland Dysfunction
    • Wuhan, Hubei, China
      Zhongnan Hospital of Wuhan University
    Oct 27, 2023

    Localized Prostate Carcinoma, Castration-Naive Prostate Cancer, Intermediate Risk Prostate Cancer Trial in Turku (Degarelix,

    Not yet recruiting
    • Localized Prostate Carcinoma
    • +3 more
    • Degarelix
    • MRI-guided transurethral ultrasound ablation (TULSA)
    • Turku, Southwest Finland, Finland
      Turku University Hospital
    Jun 14, 2023

    Exercise in Heat in Cystic Fibrosis on Modulator Therapy.

    Recruiting
    • Cystic Fibrosis
      • Portsmouth, United Kingdom
        University of Portsmouth
      May 31, 2023

      Prostatic Tumors, Prostate Cancer, Prostate Adenocarcinoma Trial run by the National Cancer Institute (NCI) (18F-DCFPyL,

      Not yet recruiting
      • Prostatic Neoplasms
      • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Feb 2, 2023

      Xerostomia Trial (Mesenchymal stem cell, Isotonic NaCl)

      Completed
      • Xerostomia
      • Mesenchymal stem cell
      • Isotonic NaCl
      • (no location specified)
      Nov 24, 2022

      Head Neck Cancer Trial in Groningen (Submandibular Gland Stem Cell Transplantation)

      Recruiting
      • Head and Neck Cancer
      • Submandibular Gland Stem Cell Transplantation
      • Groningen, Netherlands
        UMCG
      May 24, 2022

      Xerostomia Following Radiotherapy Trial in Ljubljana (allogeneic mesenchymal stromal stem cells)

      Not yet recruiting
      • Xerostomia Following Radiotherapy
      • allogeneic mesenchymal stromal stem cells
      • Ljubljana, Slovenia
      • +3 more
      Aug 22, 2023

      AAV2hAQP1 for Radiation Induced Xerostomia

      Enrolling by invitation
      • Radiation-induced Xerostomia
        • Stanford, California
        • +3 more
        Dec 22, 2022

        Dry Eye Syndromes, Meibomian Gland Dysfunction Trial (Actual IPL, Sham IPL, LLLT)

        Not yet recruiting
        • Dry Eye Syndromes
        • Meibomian Gland Dysfunction
        • Actual IPL
        • +2 more
        • (no location specified)
        Aug 21, 2023

        Characterization of Prostate Cancer With 3T MR

        Active, not recruiting
        • Prostate Cancer
          • Boston, Massachusetts
            Beth Israel Deaconess Medical Center
          Jan 26, 2023

          Primary Sjogren's Syndrome Trial in Palo Alto (tibulizumab (LY3090106))

          Withdrawn
          • Primary Sjogren's Syndrome
          • tibulizumab (LY3090106)
          • Palo Alto, California
            Stanford University
          Jan 12, 2022

          Radiotracer, Hypertension, Cholesterol Trial in Ann Arbor (Dexamethasone (Group 2), Cosyntropin (Group 3), PET/CT Scan with

          Recruiting
          • Radiotracer
          • +2 more
          • Dexamethasone (Group 2)
          • +2 more
          • Ann Arbor, Michigan
            University of Michigan
          Dec 9, 2022

          Rheumatoid Arthritis, Sjogren's Syndrome, Sicca, Asthenia, Polyalgia Syndrome (SAPS) Trial in Clermont-Ferrand (Ultrasound of

          Recruiting
          • Rheumatoid Arthritis
          • +2 more
          • Ultrasound of the salivary glands
          • +2 more
          • Clermont-Ferrand, France
            CHU de Clermont-Ferrand
          Mar 22, 2023

          Penn SICCA Follow-up Study

          Not yet recruiting
          • Dry Eye
          • Sjogren's Syndrome
            • Philadelphia, Pennsylvania
              Scheie Eye Institute
            Jan 7, 2022

            Pituitary Tumors and Related Hypothalmic Disorders

            Recruiting
            • Panhypopituitarism
            • +3 more
            • MRI
            • Tissue specimen collection
            • Bethesda, Maryland
              National Institutes of Health Clinical Center
            Jan 25, 2023

            Systemic Sclerosis Trial in Brest, Rennes, Tours (Minor Salivary gland Biopsy, ARFI, MSG US)

            Completed
            • Systemic Sclerosis
            • Minor Salivary gland Biopsy
            • +2 more
            • Brest, France
            • +2 more
            Apr 4, 2022

            Prostate Cancer Trial (Radiotherapy standard, Radiotherapy Hypo-FLAME)

            Not yet recruiting
            • Prostate Cancer
            • Radiotherapy standard
            • Radiotherapy Hypo-FLAME
            • (no location specified)
            Jan 30, 2023

            CASE 1320: RAI Uptake and Serum Prolactin in Thyroid Cancer

            Enrolling by invitation
            • Thyroid Cancer
              • Cleveland, Ohio
                Cleveland Clinic
              Aug 9, 2021

              Carcinoma of Prostate Trial in Toronto (18F-DCFPyL)

              Active, not recruiting
              • Carcinoma of Prostate
              • 18F-DCFPyL
              • Toronto, Ontario, Canada
                Princess Margaret Cancer Centre
              Oct 31, 2022